Citation

BibTex format

@article{Jenkin:2025:10.1183/23120541.00235-2025,
author = {Jenkin, I and Dimopoulos, K and Nathan, SD and Herbert, S and Dawes, T and Bax, S and McCabe, C and Nashat, H and Rawal, B and Mukherjee, B and Kouranos, V and Kokosi, M and Wells, AU and Renzoni, E and Molyneaux, P and Jenkins, G and George, PM and Wort, SJ and Price, LC},
doi = {10.1183/23120541.00235-2025},
journal = {ERJ Open Res},
title = {Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype.},
url = {http://dx.doi.org/10.1183/23120541.00235-2025},
volume = {11},
year = {2025}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - This is the first study to compare well-phenotyped patients with ILD-PH in a single centre. Unlike broader cohorts, once PH is severe enough to warrant RHC, survival appears independent of the underlying ILD subtype when comparing IPF-PH with non-IPF-PH. https://bit.ly/3IimPxW.
AU - Jenkin,I
AU - Dimopoulos,K
AU - Nathan,SD
AU - Herbert,S
AU - Dawes,T
AU - Bax,S
AU - McCabe,C
AU - Nashat,H
AU - Rawal,B
AU - Mukherjee,B
AU - Kouranos,V
AU - Kokosi,M
AU - Wells,AU
AU - Renzoni,E
AU - Molyneaux,P
AU - Jenkins,G
AU - George,PM
AU - Wort,SJ
AU - Price,LC
DO - 10.1183/23120541.00235-2025
PY - 2025///
SN - 2312-0541
TI - Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype.
T2 - ERJ Open Res
UR - http://dx.doi.org/10.1183/23120541.00235-2025
UR - https://www.ncbi.nlm.nih.gov/pubmed/41438847
VL - 11
ER -